Clinical Trials Browser

Phase 2 × Recruiting × Non-squamous Non-small Cell Lung Cancer × Clear all

NCT07264816 2026-03-05

A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC

Phase 2 Recruiting

Non-squamous Non-small Cell Lung Cancer